Apr 20, 2017· Comment from American Pharmacists Association (APhA)· FDA-2016-N-1149-0099
Please see attached for comments from the American Pharmacists Association
FDANonrulemakingFDA-2016-N-1149
Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products
RIN
—
Last modified
Jan 6, 2025
Comment window
closed 3387d ago
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Apr 20, 2017 and Apr 20, 2017. 13 other organizations filed here. The comment window closed 3387d ago.
What American Pharmacists Association (APhA) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (13)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- & Treatment Action Groupunverified attribution1 filing · confidence 70%
- Advanced Medical Technology Associationtrade assoc.1 filing · confidence 97%
- Alliance of Specialty Medicinetrade assoc.1 filing · confidence 85%
- American Academy of Dermatology Associationtrade assoc.1 filing · confidence 85%
- American Association of Tissue Banks (AATB) and the AATB Tissue Policy Grouptrade assoc.1 filing · confidence 85%
- American Medical Associationtrade assoc.1 filing · confidence 97%
- American Society of Cataract and Refractive Surgerytrade assoc.1 filing · confidence 85%
- Animal Health Institutetrade assoc.1 filing · confidence 97%
- Global Healthy Living Foundationtrade assoc.1 filing · confidence 85%
- National Multiple Sclerosis Societytrade assoc.1 filing · confidence 85%
- National Pharmaceutical Counciltrade assoc.1 filing · confidence 85%
- US Pain Foundationtrade assoc.1 filing · confidence 85%
- Washington Legal Foundationtrade assoc.1 filing · confidence 85%